EE278 Model-Projected Long-Term Clinical Outcomes of Exagamglogene Autotemcel (exa-cel) Gene-Edited Therapy in Patients with Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in the United Kingdom
Dec 1, 2023, 00:00 AM
10.1016/j.jval.2023.09.544
https://www.valueinhealthjournal.com/article/S1098-3015(23)03674-4/fulltext
Section Title :
Section Order :
10035
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03674-4&doi=10.1016/j.jval.2023.09.544